NasdaqGS:AMGNBiotechs
Amgen (AMGN) Stock Could Be A Bargain On Cash Flow But Fairly Priced On Earnings
Amgen stock has delivered an 88.5% total return over the past five years, and the latest Discounted Cash Flow (DCF) estimate currently points to the shares trading at a 43.0% discount to intrinsic value, while broader valuation checks paint a more mixed picture.
Over five years, Amgen has returned 88.5%, which puts current investors in a strong position and raises the question of how much of the story is already reflected in the share price.
Management confidence around a broad portfolio of...